Results of the TITRATION study: a 12-week, multicenter, randomized, double-blind, safety evaluation of a 3-versus 6-week up-titration regimen of LCZ696 in patients with HFrEF
![](/xmlui/themes/Mirage2//images/mime.png)
Date
2015Author
Senni, M.Reyes, A.
Majercak, I.
Andreka, P.
Mcintyre, H.
Shehova, N.
Anand, I.
Yilmaz, M. B.
Chen, F.
Charney, A.
Metadata
Show full item recordAbstract
…
Source
EUROPEAN JOURNAL OF HEART FAILUREVolume
17Collections
- Bildiri Koleksiyonu [655]
- Öksüz Yayınlar Koleksiyonu - WoS [6162]